skip to Main Content
Contact Us!

Your Name (required)

Your Email (required)

Your Message

I have read and agree to the privacy policy

Golden Jubilee National Hospital
Agamemnon Street
Glasgow G81 4HX
United Kingdom
tel.: 4401419515000
fax: 44141 951 5859 (fax)

Nawwar Al Attar, FRCS, FETCS, PhD
Nawwar Al Attar, FRCS, FETCS, PhD


Member of the French College of Perfusion
Member of the European Association for Cardio-Thoracic Surgery
Member of the French Society for Thoracic and Cardio-vascular Surgery
Member, nucleus group, task force, reviewer, of the European Society of Cardiology
Member of the Acute Cardiovascular Care Association
Consultant for Faculty 1000 Medicine in Thoracic and Cardio-vascular Surgery
Member of “Young Practitioners Review The Literature” and “Read & React”, EuroPCR
PI for the Heart Theme group, Institute of Cardiovascular & Medical Sciences, University of Glasgow

Expert at the Agence de la Biomédecine, France
Member of the Cardio-Thoracic Advisory Group (NHS BT)

Associate Professor of Cardiovascular and Thoracic Surgery. Faculty of Medicine, University Denis Diderot Paris 7, Paris.
Lecturer, Masters in Cardiovascular Devices, Bioengineering Unit, University of Strathclyde, Glasgow, UK
Examiner, Objective Structured Clinical Examination (OSCE) examiner, School of Medicine, University of Glasgow, UK
Educational Supervisor, Intercollegiate Surgical Curriculum Programme


Consultant Cardiac Surgeon -Transplantation
Honorary Clinical Associate Professor, University of Glasgow
Fellow of the European Board of Thoracic and Cardiovascular Surgeons
Member of the French College of Thoracic and Cardiovascular Surgery


Pure arterial CABG
Heart failure, transplantation and Cellular therapy
TAVI and Valvular repair surgery
Atrial fibrillation surgery
Minimally invasive techniques


• PREVAIL TA (Transapical Placement of AoRtic Balloon Expandable Transcatheter VAlves TrIaL– Europe)
• ISCHEMIA trial
• NOBLE trial (CABG vs. PCI in LMS disease)
• GLP1 study in ischaemic cardiomyopathy
• Angiogenesis and stem cell therapy in sternal breakdown after PITA CABG
• The fibrin pad CV phase III study
• REACH trial (C-pulse device)
• TAVI-UK Trial
• VICTORY CT001 Study

Back To Top